Technical Analysis for LNTH - Lantheus Holdings, Inc.

Grade Last Price % Change Price Change
D 25.6 -0.16% -0.04
LNTH closed down 0.16 percent on Friday, September 17, 2021, on 2.18 times normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical LNTH trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Cup with Handle Other 0.00%
20 DMA Resistance Bearish -0.16%
Pocket Pivot Bullish Swing Setup -0.16%
Cup with Handle Other -0.16%
Cup with Handle Other 0.75%
Outside Day Range Expansion 0.75%
Oversold Stochastic Weakness 0.75%
MACD Bearish Centerline Cross Bearish 4.15%
Older End-of-Day Signals for LNTH ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 22 hours ago
Down 1% about 22 hours ago
Possible NR7 about 23 hours ago
20 DMA Resistance 1 day ago
10 DMA Resistance 1 day ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Lantheus Holdings, Inc. Description

Lantheus Holdings, Inc. is engaged in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. The Company's medical imaging agents are used to diagnose coronary artery disease, congestive heart failure, stroke, peripheral vascular disease and other diseases. The Company's products include contrast agents and medical radiopharmaceuticals, including technetium generators. The Company's products include DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, Neurolite, Thallium Tl 201, Gallium Ga 67, Gludef, Quadramet and Ablavar. The Company is also engaged in developing agents, such as Flurpiridaz F 18, which is a myocardial perfusion imaging agent; 18F LMI 1195, which is a cardiac neuronal imaging agent, and LMI 1174, which is a vascular remodeling imaging agent.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Diseases Chemical Elements Prostate Cancer Heart Failure Medical Imaging Stroke Medical Physics Artery Perfusion Artery Disease Neuron Gallium Imaging Agent Peripheral Vascular Disease Radiopharmaceuticals Congestive Heart Failure Coronary Artery Disease Cardiovascular And Other Diseases Medicinal Radiochemistry Myocardial Perfusion Imaging

Is LNTH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 28.67
52 Week Low 10.52
Average Volume 372,015
200-Day Moving Average 21.44
50-Day Moving Average 25.87
20-Day Moving Average 25.78
10-Day Moving Average 25.79
Average True Range 0.84
ADX 11.92
+DI 24.08
-DI 22.98
Chandelier Exit (Long, 3 ATRs) 25.08
Chandelier Exit (Short, 3 ATRs) 26.43
Upper Bollinger Bands 27.20
Lower Bollinger Band 24.37
Percent B (%b) 0.44
BandWidth 10.97
MACD Line -0.08
MACD Signal Line -0.01
MACD Histogram -0.0674
Fundamentals Value
Market Cap 1.71 Billion
Num Shares 66.9 Million
EPS 0.01
Price-to-Earnings (P/E) Ratio 3200.00
Price-to-Sales 1.87
Price-to-Book 1.71
PEG Ratio 0.61
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 26.66
Resistance 3 (R3) 26.63 26.25 26.48
Resistance 2 (R2) 26.25 25.98 26.26 26.42
Resistance 1 (R1) 25.92 25.81 25.73 25.95 26.36
Pivot Point 25.54 25.54 25.45 25.56 25.54
Support 1 (S1) 25.22 25.28 25.03 25.25 24.84
Support 2 (S2) 24.84 25.11 24.85 24.78
Support 3 (S3) 24.52 24.84 24.72
Support 4 (S4) 24.54